Steven Gillis's Net Worth

$642 Million

Who is Steven Gillis?

Steven Gillis has an estimated net worth of $642 Million. This is based on reported shares across multiple companies, which include Sana Biotechnology, Inc., VBI VACCINES INC., PHASERX, INC., Neumora Therapeutics, Inc., Trubion Pharmaceuticals, Inc, VBI Vaccines Inc/BC, DA32 Life Science Tech Acquisition Corp., Erasca, Inc., Pulmatrix, Inc., Verve Therapeutics, Inc., bluebird bio, Inc., Codiak BioSciences, Inc., Sienna Biopharmaceuticals, Inc., Homology Medicines, Inc., Prime Medicine, Inc., and CORIXA CORP.

SEC CIK

Steven Gillis's CIK is 0001229592

Past Insider Trading and Trends

2023 was Steven Gillis's most active year for acquiring shares with 29 total transactions. Steven Gillis's most active month to acquire stocks was the month of May. 2005 was Steven Gillis's most active year for disposing of shares, totalling 22 transactions. Steven Gillis's most active month to dispose stocks was the month of June. 2023 saw Steven Gillis paying a total of $32,435,022.58 for 20,200,108 shares, this is the most they've acquired in one year. In 2014 Steven Gillis cashed out on 752,477 shares for a total of $9,305,060.48, their largest year based on trade value.